{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T17:06:42Z","timestamp":1788887202124,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":5,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Valencian Pneumology Society","award":["UGP-19-483"],"award-info":[{"award-number":["UGP-19-483"]}]},{"name":"GlaxoSmithKline","award":["CPRES00124"],"award-info":[{"award-number":["CPRES00124"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-025-04020-1","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T12:03:33Z","timestamp":1771070613000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Inflammatory phenotype drives different immunosuppressive response in COPD exacerbations"],"prefix":"10.1186","volume":"26","author":[{"given":"Cristina","family":"Miralles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Dolores","family":"Mi\u00f1ana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luisa","family":"Nieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"del Carmen Aguar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Dom\u00ednguez-M\u00e1rquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jos\u00e9","family":"Soler-Catalu\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,14]]},"reference":[{"key":"4020_CR1","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1152\/physrev.00036.2021","volume":"103","author":"F Kheradmand","year":"2023","unstructured":"Kheradmand F, Zhang Y, Corry DB. Contribution of adaptive immunity to human COPD and experimental models of emphysema. Physiol Rev. 2023;103:1059\u201393.","journal-title":"Physiol Rev"},{"key":"4020_CR2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/mi.2013.77","volume":"7","author":"SD Pouwels","year":"2014","unstructured":"Pouwels SD, Heijink IH, ten Hacken NHT, Vandenabeele P, Krysko DV, Nawijn MC, et al. DAMPs activating innate and adaptive immune responses in COPD. Mucosal Immunol. 2014;7:215\u201326.","journal-title":"Mucosal Immunol"},{"key":"4020_CR3","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1111\/all.13760","volume":"74","author":"PJ Barnes","year":"2019","unstructured":"Barnes PJ. Inflammatory endotypes in COPD. Allergy. 2019;74:1249\u201356.","journal-title":"Allergy"},{"key":"4020_CR4","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1164\/ajrccm.150.6.7952628","volume":"150","author":"M Saetta","year":"1994","unstructured":"Saetta M, Di Stefano A, Maestrelli P, Turato G, Ruggieri MP, Roggeri A, et al. Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med. 1994;150:1646\u201352.","journal-title":"Am J Respir Crit Care Med"},{"key":"4020_CR5","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1183\/09031936.00162414","volume":"44","author":"D Singh","year":"2014","unstructured":"Singh D, Kolsum U, Brightling CE, Locantore N, Agusti A, Tal-Singer R, et al. Eosinophilic inflammation in COPD: prevalence and clinical characteristics. Eur Respir J. 2014;44:1697\u2013700.","journal-title":"Eur Respir J"},{"key":"4020_CR6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1164\/rccm.202201-0209PP","volume":"206","author":"D Singh","year":"2022","unstructured":"Singh D, Agusti A, Martinez FJ, Papi A, Pavord ID, Wedzicha JA, et al. Blood eosinophils and chronic obstructive pulmonary disease: A global initiative for chronic obstructive lung disease science committee 2022 review. Am J Respir Crit Care Med. 2022;206:17\u201324.","journal-title":"Am J Respir Crit Care Med"},{"key":"4020_CR7","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S2213-2600(15)00106-X","volume":"3","author":"S Pascoe","year":"2015","unstructured":"Pascoe S, Locantore N, Dransfield MT, Barnes NC, Pavord ID. Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to Vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials. Lancet Respir Med. 2015;3:435\u201342.","journal-title":"Lancet Respir Med"},{"key":"4020_CR8","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/archsurg.134.6.666","volume":"134","author":"PA Ward","year":"1999","unstructured":"Ward PA, Lentsch AB. The acute inflammatory response and its regulation. Arch Surg. 1999;134:666\u20139.","journal-title":"Arch Surg"},{"key":"4020_CR9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.semcancer.2012.02.008","volume":"22","author":"J Kanterman","year":"2012","unstructured":"Kanterman J, Sade-Feldman M, Baniyash M. New insights into chronic inflammation-induced immunosuppression. Semin Cancer Biol. 2012;22:307\u201318.","journal-title":"Semin Cancer Biol"},{"key":"4020_CR10","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3389\/fimmu.2020.00723","volume":"11","author":"J Hou","year":"2020","unstructured":"Hou J, Sun Y. Role of regulatory T cells in disturbed immune homeostasis in patients with chronic obstructive pulmonary disease. Front Immunol. 2020;11:723.","journal-title":"Front Immunol"},{"key":"4020_CR11","doi-asserted-by":"crossref","first-page":"e111044","DOI":"10.1371\/journal.pone.0111044","volume":"9","author":"Y Jin","year":"2014","unstructured":"Jin Y, Wan Y, Chen G, Chen L, Zhang MQ, Deng L, et al. Treg\/IL-17 ratio and Treg differentiation in patients with COPD. PLoS ONE. 2014;9:e111044.","journal-title":"PLoS ONE"},{"key":"4020_CR12","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/thoraxjnl-2012-201956","volume":"68","author":"J Hou","year":"2013","unstructured":"Hou J, Sun Y, Hao Y, Zhuo J, Liu X, Bai P, et al. Imbalance between subpopulations of regulatory T cells in COPD. Thorax. 2013;68:1131\u20139.","journal-title":"Thorax"},{"key":"4020_CR13","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.2147\/COPD.S208977","volume":"14","author":"ZJ Meng","year":"2019","unstructured":"Meng ZJ, Wu JH, Zhou M, Sun SW, Miao SY, Han HL, et al. Peripheral blood CD4\u2009+\u2009T cell populations by CD25 and Foxp3 expression as a potential biomarker: reflecting inflammatory activity in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2019;14:1669\u201380.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"4020_CR14","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.biopha.2018.09.113","volume":"108","author":"X Zheng","year":"2018","unstructured":"Zheng X, Zhang L, Chen J, Gu Y, Xu J, Ouyang Y. Dendritic cells and Th17\/Treg ratio play critical roles in pathogenic process of chronic obstructive pulmonary disease. Biomed Pharmacother. 2018;108:1141\u201351.","journal-title":"Biomed Pharmacother"},{"key":"4020_CR15","first-page":"5324","volume":"7","author":"XN Li","year":"2014","unstructured":"Li XN, Pan X, Qiu D. Imbalances of Th17 and Treg cells and their respective cytokines in COPD patients by disease stage. Int J Clin Exp Med. 2014;7:5324\u20139.","journal-title":"Int J Clin Exp Med"},{"key":"4020_CR16","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/crj.12147","volume":"9","author":"H Wang","year":"2015","unstructured":"Wang H, Ying H, Wang S, Gu X, Weng Y, Peng W, et al. Imbalance of peripheral blood Th17 and Treg responses in patients with chronic obstructive pulmonary disease. Clin Respir J. 2015;9:330\u201341.","journal-title":"Clin Respir J"},{"key":"4020_CR17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12931-022-02058-x","volume":"23","author":"XF Xiong","year":"2022","unstructured":"Xiong XF, Zhu M, Wu HX, Fan LL, Cheng DY. Immunophenotype in acute exacerbation of chronic obstructive pulmonary disease: a cross-sectional study. Respir Res. 2022;23:137.","journal-title":"Respir Res"},{"key":"4020_CR18","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1183\/13993003.01572-2015","volume":"47","author":"S Kolahian","year":"2016","unstructured":"Kolahian S, \u00d6z HH, Zhou B, Griessinger CM, Rieber N, Hartl D. The emerging role of myeloid-derived suppressor cells in lung diseases. Eur Respir J. 2016;47:967\u201377.","journal-title":"Eur Respir J"},{"key":"4020_CR19","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","volume":"9","author":"DI Gabrilovich","year":"2009","unstructured":"Gabrilovich DI, Nagaraj S. Myeloid-derived-suppressor cells as regulators of the immune system. Nat Rev Immunol. 2009;9:162\u201374.","journal-title":"Nat Rev Immunol"},{"key":"4020_CR20","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.rmed.2013.08.002","volume":"107","author":"S Scrimini","year":"2013","unstructured":"Scrimini S, Pons J, Agust\u00ed A, Soriano BG, Torrecilla JA, N\u00fa\u00f1ez B, et al. Differential effects of smoking and COPD upon Circulating myeloid derived suppressor cells. Respir Med. 2013;107:1895\u2013903.","journal-title":"Respir Med"},{"key":"4020_CR21","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.3389\/fimmu.2017.01895","volume":"8","author":"A Dorhoi","year":"2017","unstructured":"Dorhoi A, Du Plessis N. Monocytic myeloid-derived suppressor cells in chronic infections. Front Immunol. 2017;8:1895.","journal-title":"Front Immunol"},{"key":"4020_CR22","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1164\/rccm.201104-0597OC","volume":"184","author":"M Bafadhel","year":"2011","unstructured":"Bafadhel M, McKenna S, Terry S, Mistry V, Reid C, Haldar P, et al. Acute exacerbations of chronic obstructive pulmonary disease. Identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med. 2011;184:662\u201371.","journal-title":"Am J Respir Crit Care Med"},{"key":"4020_CR23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.clim.2017.11.003","volume":"195","author":"SL Qiu","year":"2018","unstructured":"Qiu SL, Kuang LJ, Tang QY, Duan MC, Bai J, He ZY, et al. Enhanced activation of Circulating plasmacytoid dendritic cells in patients with chronic obstructive pulmonary disease and experimental smoking-induced emphysema. Clin Immunol. 2018;195:107\u201318.","journal-title":"Clin Immunol"},{"key":"4020_CR24","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1165\/rcmb.2016-0272TR","volume":"56","author":"CM Freeman","year":"2017","unstructured":"Freeman CM, Curtis JL. Lung dendritic cells: shaping immune responses throughout chronic obstructive pulmonary disease progression. Am J Respir Cell Mol Biol. 2017;56:152\u20139.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"4020_CR25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12931-019-1268-7","volume":"21","author":"TH Harries","year":"2020","unstructured":"Harries TH, Rowland V, Corrigan CJ, Marshall IJ, McDonnell L, Prasad V, et al. Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis. Respir Res. 2020;21:3.","journal-title":"Respir Res"},{"key":"4020_CR26","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3389\/fimmu.2017.00832","volume":"8","author":"NB Crux","year":"2017","unstructured":"Crux NB, Elahi S. Human leukocyte antigen (HLA) and immune regulation: how do classical and non-classical HLA alleles modulate immune response to human immunodeficiency virus and hepatitis C virus infections? Front Immunol. 2017;8:832.","journal-title":"Front Immunol"},{"key":"4020_CR27","doi-asserted-by":"crossref","first-page":"e57678","DOI":"10.1371\/journal.pone.0057678","volume":"8","author":"P Gao","year":"2013","unstructured":"Gao P, Zhang J, He X, Hao Y, Wang K, Gibson PG. Sputum inflammatory cell-based classification of patients with acute exacerbation of chronic obstructive pulmonary disease. PLoS ONE. 2013;8:e57678.","journal-title":"PLoS ONE"},{"key":"4020_CR28","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/thoraxjnl-2017-210408","volume":"73","author":"D Mayhew","year":"2018","unstructured":"Mayhew D, Devos N, Lambert C, Brown JR, Clarke SC, Kim VL, et al. Longitudinal profiling of the lung Microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations. Thorax. 2018;73:422\u201330.","journal-title":"Thorax"},{"key":"4020_CR29","doi-asserted-by":"crossref","first-page":"2000391","DOI":"10.1183\/13993003.00391-2020","volume":"56","author":"HR Keir","year":"2020","unstructured":"Keir HR, Dicker A, Lonergan M, Crichton M, Miller BE, Tal-Singer R, et al. Clinical endotypes of exacerbation are associated with differences in microbial composition and diversity in COPD. Eur Respir J. 2020;56:2000391.","journal-title":"Eur Respir J"},{"key":"4020_CR30","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1164\/rccm.202009-3448OC","volume":"203","author":"Z Wang","year":"2021","unstructured":"Wang Z, Locantore N, Haldar K, Ramsheh MY, Beech AS, Ma W, et al. Inflammatory endotype-associated airway Microbiome in chronic obstructive pulmonary disease clinical stability and exacerbations: A multicohort longitudinal analysis. Am J Respir Crit Care Med. 2021;203:1488\u2013502.","journal-title":"Am J Respir Crit Care Med"},{"key":"4020_CR31","doi-asserted-by":"crossref","first-page":"989","DOI":"10.4049\/jimmunol.172.2.989","volume":"172","author":"S Kusmartsev","year":"2004","unstructured":"Kusmartsev S, Nefedova Y, Yoder D, Gabrilovich DI. Antigen-specific Inhibition of CD8\u2009+\u2009T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. J Immunol. 2004;172:989\u201399.","journal-title":"J Immunol"},{"key":"4020_CR32","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.4049\/jimmunol.1400196","volume":"194","author":"C Tebartz","year":"2015","unstructured":"Tebartz C, Horst SA, Sparwasser T, Huehn J, Beineke A, Peters G, et al. A major role for myeloid-derived suppressor cells and a minor role for regulatory T cells in immunosuppression during Staphylococcus aureus infection. J Immunol. 2015;194:1100\u201311.","journal-title":"J Immunol"},{"key":"4020_CR33","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3390\/ijms19030869","volume":"19","author":"CR Lee","year":"2018","unstructured":"Lee CR, Lee W, Cho SK, Park SG. Characterization of multiple cytokine combinations and TGF-\u03b2 on differentiation and functions of myeloid-derived suppressor cells. Int J Mol Sci. 2018;19:869.","journal-title":"Int J Mol Sci"},{"key":"4020_CR34","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/ni1488","volume":"8","author":"L Zhou","year":"2007","unstructured":"Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, Egawa T, et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol. 2007;8:967\u201374.","journal-title":"Nat Immunol"},{"key":"4020_CR35","doi-asserted-by":"crossref","first-page":"e0142881","DOI":"10.1371\/journal.pone.0142881","volume":"10","author":"HH Chen","year":"2015","unstructured":"Chen HH, Sun AH, Ojcius DM, Hu WL, Ge YM, Lin X, et al. Eosinophils from murine lamina propria induce differentiation of na\u00efve T cells into regulatory T cells via TGF-\u03b21 and retinoic acid. PLoS ONE. 2015;10:e0142881.","journal-title":"PLoS ONE"},{"key":"4020_CR36","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s13238-012-2104-8","volume":"4","author":"M Bao","year":"2013","unstructured":"Bao M, Liu YJ. Regulation of TLR7\/9 signaling in plasmacytoid dendritic cells. Protein Cell. 2013;4:40\u201352.","journal-title":"Protein Cell"},{"key":"4020_CR37","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.4049\/jimmunol.179.6.3937","volume":"179","author":"U Bhan","year":"2007","unstructured":"Bhan U, Lukacs NW, Osterholzer JJ, Newstead MW, Zeng X, Moore TA, et al. TLR9 is required for protective innate immunity in Gram-negative bacterial pneumonia: role of dendritic cells. J Immunol. 2007;179:3937\u201346.","journal-title":"J Immunol"},{"key":"4020_CR38","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/jleuko\/qiae003","volume":"115","author":"E Steinacher","year":"2024","unstructured":"Steinacher E, Lenz M, Krychtiuk KA, Hengstenberg C, Huber K, Wojta J, et al. Decreased percentages of plasmacytoid dendritic cells predict survival in critically ill patients. J Leukoc Biol. 2024;115:902\u201312.","journal-title":"J Leukoc Biol"},{"key":"4020_CR39","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1086\/428589","volume":"191","author":"MA Gill","year":"2005","unstructured":"Gill MA, Palucka AK, Barton T, Ghaffar F, Jafri H, Banchereau J, et al. Mobilization of plasmacytoid and myeloid dendritic cells to mucosal sites in children with respiratory syncytial virus and other viral respiratory infections. J Infect Dis. 2005;191:1105\u201315.","journal-title":"J Infect Dis"},{"key":"4020_CR40","doi-asserted-by":"crossref","first-page":"450957","DOI":"10.1155\/2015\/450957","volume":"2015","author":"D Kretzschmar","year":"2015","unstructured":"Kretzschmar D, Rohm I, Sch\u00e4ller S, Betge S, Pistulli R, Atiskova Y, et al. Decrease in Circulating dendritic cell precursors in patients with peripheral artery disease. Mediators Inflamm. 2015;2015:450957.","journal-title":"Mediators Inflamm"},{"key":"4020_CR41","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2147\/COPD.S485246","volume":"20","author":"M Donnan","year":"2025","unstructured":"Donnan M, Liu TL, Gvalda M, Chen X, Foo CT, MacDonald MI, et al. Clinical characteristics and outcomes of eosinophilic exacerbations of COPD. Int J Chron Obstruct Pulmon Dis. 2025;20:1061\u201370.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"4020_CR42","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12890-021-01443-4","volume":"21","author":"HS Kang","year":"2021","unstructured":"Kang HS, Kim SK, Kim YH, Kim JW, Lee SH, Yoon HK, et al. The association between eosinophilic exacerbation and eosinophilic levels in stable COPD. BMC Pulm Med. 2021;21:74.","journal-title":"BMC Pulm Med"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-025-04020-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-04020-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-04020-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T22:06:02Z","timestamp":1771538762000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12890-025-04020-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,14]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4020"],"URL":"https:\/\/doi.org\/10.1186\/s12890-025-04020-1","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,14]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of the Arnau de Vilanova Hospital, Valencia, Spain. All participants gave their informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"JJSC has received speaker fees from AstraZeneca, Bial, Boehringer Ingelheim, Chiesi, FAES, GlaxoSmithKline, Grifols, Menarini and Sanofi, and consulting fees from AstraZeneca, Bial, Chiesi, GSK, Grifols and Sanofi, and grants from GSK. The rest of authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"86"}}